Karlsson et al. [36] have reported that CIMP shows differences in adenocarcinomas and it is associated with mutation frequency of common tumor suppressor genes such as KEAP1, TP53, STK11, and SMARCA4. The gene discussed is TP53; the disease is adenocarcinoma.